Zus Health is a next-generation shared health data platform centered on the Zus Aggregated Profile (ZAP), which provides a single, comprehensive, actionable view of a patient’s healthcare information. The platform includes a FHIR-native data store and common patient record technology to enable real-time, cross-provider insights. Zus plans to use its recently closed $40 million financing to add unique data sources, build workflow and referral solutions, and expand integration pathways so providers can leverage external patient data and collaborate around a shared record. The company is integrating ZAP with partners such as Elation Health, which supports millions of patients, enabling clinicians to access expanded patient records from hospitals, clinics, labs, and pharmacies in real time. Zus positions its product to reduce clinician time spent gathering and entering data, decrease duplicated tests and procedures, and improve care coordination and outcomes. The company intends to scale the platform to become a go-to source of aggregated health records for Americans, replacing unstructured PDFs and faxes with an always-on network of healthcare insights. Zus Health builds an industry-first shared development platform backed by a shared data record, combining a FHIR-native, never-overwritten, patient-centric multi-tenant health record with tools for builders. Its stack includes healthcare workflow libraries, data acquisition and enrichment services, patient identity and control, and the ability for builders to store proprietary data logically joined to the patient record. Zus launched with four builders on its platform: Cityblock Health, Dorsata, Firefly Health and Oak Street Health. The company intends to use the funding to grow its engineering team and invest in the platform, tools and products that support digital-first healthcare builders. Zus positions itself to reduce redundancy in healthcare technology by enabling information sharing and lowering the cost and time to build clinical and experience-layer applications. The company emphasizes a network effect from shared data to improve clinical value and accelerate innovation among its builder community.

Total raised

$74M

Funding rounds

2

Latest round

Equity

Latest activity

Mar 2023